JP2023514738A5 - - Google Patents

Info

Publication number
JP2023514738A5
JP2023514738A5 JP2022550720A JP2022550720A JP2023514738A5 JP 2023514738 A5 JP2023514738 A5 JP 2023514738A5 JP 2022550720 A JP2022550720 A JP 2022550720A JP 2022550720 A JP2022550720 A JP 2022550720A JP 2023514738 A5 JP2023514738 A5 JP 2023514738A5
Authority
JP
Japan
Prior art keywords
treatment
nrg
probnp
patient
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022550720A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023514738A (ja
JP7807815B2 (ja
Filing date
Publication date
Priority claimed from CN202010174086.5A external-priority patent/CN113289002A/zh
Application filed filed Critical
Publication of JP2023514738A publication Critical patent/JP2023514738A/ja
Publication of JP2023514738A5 publication Critical patent/JP2023514738A5/ja
Priority to JP2025205790A priority Critical patent/JP2026062640A/ja
Application granted granted Critical
Publication of JP7807815B2 publication Critical patent/JP7807815B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022550720A 2020-02-24 2021-02-19 ニューレグリンの使用による心不全を予防、治療、又は遅延させるための方法及び組成物 Active JP7807815B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025205790A JP2026062640A (ja) 2020-02-24 2025-11-27 ニューレグリンの使用による心不全を予防、治療、又は遅延させるための方法及び組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202010113391.3 2020-02-24
CN202010113391 2020-02-24
CN202010174086.5A CN113289002A (zh) 2020-02-24 2020-03-13 神经调节蛋白用于预防、治疗或延缓心力衰竭的方法和组合物
CN202010174086.5 2020-03-13
PCT/CN2021/076772 WO2021169845A1 (zh) 2020-02-24 2021-02-19 神经调节蛋白用于预防、治疗或延缓心力衰竭的方法和组合物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025205790A Division JP2026062640A (ja) 2020-02-24 2025-11-27 ニューレグリンの使用による心不全を予防、治療、又は遅延させるための方法及び組成物

Publications (3)

Publication Number Publication Date
JP2023514738A JP2023514738A (ja) 2023-04-07
JP2023514738A5 true JP2023514738A5 (enExample) 2024-02-29
JP7807815B2 JP7807815B2 (ja) 2026-01-28

Family

ID=77317937

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022550720A Active JP7807815B2 (ja) 2020-02-24 2021-02-19 ニューレグリンの使用による心不全を予防、治療、又は遅延させるための方法及び組成物
JP2025205790A Pending JP2026062640A (ja) 2020-02-24 2025-11-27 ニューレグリンの使用による心不全を予防、治療、又は遅延させるための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025205790A Pending JP2026062640A (ja) 2020-02-24 2025-11-27 ニューレグリンの使用による心不全を予防、治療、又は遅延させるための方法及び組成物

Country Status (8)

Country Link
US (1) US20230083149A1 (enExample)
EP (1) EP4115899A4 (enExample)
JP (2) JP7807815B2 (enExample)
KR (1) KR20220145870A (enExample)
CN (2) CN113289002A (enExample)
AU (1) AU2021225283A1 (enExample)
CA (1) CA3172439A1 (enExample)
WO (1) WO2021169845A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117797243A (zh) * 2022-09-30 2024-04-02 上海泽生科技开发股份有限公司 神经调节蛋白及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE463851B (sv) 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US7115554B1 (en) 1993-05-06 2006-10-03 Acorda Therapeutics, Inc. Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5834229A (en) 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
DE4221256C2 (de) 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
US5741511A (en) 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction
US5912326A (en) 1995-09-08 1999-06-15 President And Fellows Of Harvard College Cerebellum-derived growth factors
JP2000502682A (ja) 1995-12-22 2000-03-07 ローカルメッド インコーポレイテッド 血管新生を促進する成長因子の局所的血管内デリバリー
SE9703226D0 (sv) 1997-09-08 1997-09-08 Astra Ab New pharmaceutical composition
EP1028735A4 (en) 1997-10-14 2003-08-06 Cenes Pharmaceuticals Inc THERAPEUTIC METHOD COMPRISING THE USE OF NEUREGULIN
AUPP785098A0 (en) 1998-12-21 1999-01-21 Victor Chang Cardiac Research Institute, The Treatment of heart disease
US6635249B1 (en) 1999-04-23 2003-10-21 Cenes Pharmaceuticals, Inc. Methods for treating congestive heart failure
CN1138785C (zh) 1999-06-04 2004-02-18 周明东 生长因子神经调节蛋白及其类似物的新应用
AU2002304965A1 (en) 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
CN104436167A (zh) * 2010-06-12 2015-03-25 上海泽生科技开发有限公司 神经调节蛋白用于治疗心力衰竭的有效剂量
WO2013053076A1 (en) * 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
US20160129084A1 (en) * 2013-03-06 2016-05-12 Acorda Therapeutics, Inc. Therapeutic Dosing of a Neuregulin or a Fragment Thereof for Treatment or Prophylaxis of Heart Failure
CN111407882A (zh) * 2014-10-17 2020-07-14 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物
CN110835368A (zh) * 2018-08-15 2020-02-25 上海泽生科技开发股份有限公司 神经调节蛋白多肽片段及其用途

Similar Documents

Publication Publication Date Title
Silva et al. The carboxyl-terminal region of the Na+/H+ exchanger interacts with mammalian heat shock protein
Hibert et al. Apolipoprotein aI is a potential mediator of remote ischemic preconditioning
Pulimeno et al. PLEKHA7 is an adherens junction protein with a tissue distribution and subcellular localization distinct from ZO-1 and E-cadherin
JP2002535622A (ja) 副甲状腺および骨状態関連の疾患を識別およびモニタリングする方法
EP2076537A2 (en) Prevention of tissue ischemia, related methods and compositions
WO2013072510A1 (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition
Weivoda et al. ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand
CN101988926A (zh) 一种高尔基蛋白gp73的夹心elisa定量检测方法及其检测试剂盒
JP2592121B2 (ja) ＩｇＡ腎臓病の診断のための方法及びキツト
JP2018511601A (ja) Ｖｉ型コラーゲン配列に関するイムノアッセイ
US5861238A (en) Methods for partitioning advanced glycosylation endproducts
IL322765A (en) Anti-adrenomedullin (ADM) antibody, or anti-ADM antibody fragment or non-Ig anti-ADM scaffold for use in the treatment or prevention of congestion in a patient in need thereof
Li et al. LONP1 facilitates pulmonary artery smooth muscle cell glycolytic reprogramming by degrading MPC1 in pulmonary hypertension
CN110437326B (zh) 大疱性类天疱疮BP230 IgE抗体的抗原表位多肽及其用途
Durand-Gorde et al. Production of an agonist-like monoclonal antibody to the human A2A receptor of adenosine for clinical use
JPH02479A (ja) ｓｎＲＮＰ−Ａ抗原及びそのフラグメント
CN114478787B (zh) 一种抗Gd-IgA1单克隆抗体及用于IgA肾病辅助诊断ELISA试剂盒
KR101040321B1 (ko) 심혈관 질환 진단용 바이오마커
US20240255531A1 (en) Mature adrenomedullin for therapy stratification of corticosteroids in critically ill patients
CN115515620A (zh) 神经调节蛋白用于预防、治疗或延缓心力衰竭的方法和组合物
Belous et al. The state of the serotonin transporter protein in the platelets of patients with somatoform disorders
BR0308095A (pt) Teste para anticorpos anti-ingap
WO2008112424A1 (en) Assessing heart failure
Bornholz et al. Autoantibodies directed against G-protein-coupled receptors in cardiovascular diseases: basics and diagnostics
EP2859354B1 (en) Nitrated cardiac troponin i as a biomarker of cardiac ischemia